Table 1.
Baseline characteristics of aortic stenosis patients and controls.
| Controls | AS patients | |
|---|---|---|
| n | 13 | 26 |
| Age (years) | 75 ± 11 | 74 ± 8 |
| Male | 7 (54%) | 12 (46%) |
| Hypertension | 1 (8%) | 18 (69%) |
| Hyperlipidaemia | 3 (23%) | 16 (62%) |
| Diabetes | 1 (8%) | 2 (7%) |
| Coronary artery disease | 1 (8%) | 7 (27%) |
| Lung disease | 4 (30%) | |
| Cause of death: | ||
| -Bronchopneumonia | 4 (30%) | |
| -Sepsis | 1 (8%) | |
| -Cancer | 6 (46%) | |
| -Trauma | 1 (8%) | |
| -Old age | 1 (8%) | |
| LVEF (%) | 65 ± 13 | |
| NYHA | I (11.5%) | |
| II (57.7%) | ||
| III (23.1%) | ||
| IV (7.7%) | ||
| Aldosterone (pg/ml) | 59.13 ± 32.7 | |
Values are mean ± SD. LVEF = left ventricular ejection fraction; NYHA = New York Heart Association classification of heart failure; Aldo = Aldosterone.